Strong heart study (SHS) - field center, task order 001, base period, february 15, 2019 to february 14, 2020

Active Awarded Last action

Contract number
75N92019F00074
Awardee
Awarding agency
Obligated
$3,593,572

Award facts

Opportunity
Contract value 100% obligated
$3,592,276.02 Current and potential, with all options
Completion date 96% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
UNIVERSITY PA, MD 20782, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00011 · Strong heart study (SHS) - field center - task order 001 - task a $439,717
Other Administrative Action P00009 · DE-obligation of fiscal year 2020 expiring funds -$35,700
Exercise an Option P00008 $380,811
Other Administrative Action P00007 -$48,011
Exercise an Option P00006 $454,964
Exercise an Option P00005 $422,701
Exercise an Option P00004 $406,544
Exercise an Option P00003 · Strong heart study (SHS) - field center - task order 001 $405,062
Exercise an Option P00002 · Strong heart study (SHS) - field center, task order 001, option period 1 $528,213
Other Administrative Action P00001 $639,271
Original award $0
Show all 11

About this award

Medstar Health Research Institute Inc. was awarded a $3.59 million delivery order on February 15, 2019, to serve as a field center for the Strong Heart Study (SHS), a major epidemiological research initiative funded by the National Heart, Lung, and Blood Institute (NHLBI). This cost-plus-no-fee contract, with an ultimate completion date of February 14, 2027, was awarded without set-aside designation and performs work at the contractor's facility in Chillum, Maryland. The Strong Heart Study is a long-standing, multi-center investigation focused on cardiovascular disease risk factors and outcomes in American Indian populations, and Medstar's role as a field center involves coordinating and conducting clinical research activities, patient recruitment, data collection, and study administration in support of this critical public health research effort.

Medstar Health Research Institute Inc., a non-profit subsidiary of Medstar Health, Inc., was selected based on its established track record conducting specialized clinical research and biomedical studies for the NHLBI and other federal health agencies. The organization brings extensive experience in cardiovascular research, clinical event adjudication, medical imaging support, and research coordination across multiple NIH institutes. This delivery order represents part of the organization's broader engagement with the NHLBI, which includes an indefinite delivery vehicle for cardiovascular MRI services, positioning Medstar as a trusted, long-term partner in advancing the Institute's research mission.

Quick answers

Who was awarded contract 75N92019F00074?

75N92019F00074 was awarded to Medstar Health Research Institute Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on February 15, 2019.

How much is contract 75N92019F00074 worth?

The government has obligated $3,593,572 on 75N92019F00074. Its current value, with exercised options, is $3,592,276.

Is contract 75N92019F00074 an order under another contract?

Yes. 75N92019F00074 is a delivery order under 75N92019D00030, an indefinite delivery contract.

Was contract 75N92019F00074 competed?

The extent of competition for 75N92019F00074 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award